Showing results (1741-1750 of 2,100) with videos related to

Sort By:
Pageof 210
British Journal of Haematology|April 23, 2010
Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1-2 studyBertrand Coiffier, Nedjad Losic, Birgitte Biilmann Rønn, et al.
Leukemia|January 19, 2026
Treatment-free remission after two nilotinib consolidation durations in chronic myeloid leukemia treated with imatinib: Phase 3 ENESTPath resultsDelphine Rea, Slawomira Kyrcz-Krzemien, Paolo Sportoletti, et al.
Molecular Ecology|April 29, 2014
Gene expression in closely related species mirrors local adaptation: consequences for responses to a warming worldShawn T O'Neil, Jason D K Dzurisin, Caroline M Williams, et al.
EMBO Molecular Medicine|July 5, 2022
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccinationSebastian J Theobald, Alexander Simonis, Julie M Mudler, et al.
Transplantation Proceedings|January 3, 2006
Addition of cladribine to induction/consolidation regimen does not impair peripheral blood stem cell mobilization and bone marrow harvest for autotransplantation in acute myeloid leukemia patientsJ Holowiecki, S Grosicki, M Sadus-Wojciechowska, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 15, 2021
Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse EventsJia Luo, Jason A Beattie, Paige Fuentes, et al.
Blood|April 9, 2008
First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trialAnton Hagenbeek, Ole Gadeberg, Peter Johnson, et al.
NPJ Precision Oncology|July 16, 2024
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapyArielle Elkrief, Eder Orlando Méndez-Salazar, Jade Maillou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2018
Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of ResistanceHelena A Yu, Ken Suzawa, Emmet Jordan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 23, 2021
Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumabMaria Thor, Annemarie F Shepherd, Isabel Preeshagul, et al.
Pageof 210